Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $990M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KURA | KURA ONCOLOGY ORD | 5,276,753 | $104M | 10.5% | $10.87 | +52.7% | COM | 50127T109 |
| XNCR | XENCOR ORD | 2,336,557 | $95.64M | 9.7% | $34.67 | -5.2% | COM | 98401F105 |
| ARGX | ARGENX ADR REP ORD | 581,165 | $82.28M | 8.3% | $96.07 | — | SPONSORED ADR | 04016X101 |
| CRSP | CRISPR THERAPEUTICS ORD | 1,610,250 | $75.84M | 7.7% | $36.55 | +9.3% | COM | H17182108 |
| — | FIBROGEN ORD | 1,511,785 | $68.3M | 6.9% | $44.16 | — | COM | 31572Q808 |
| — | SPARK THERAPEUTICS ORD | 614,128 | $62.87M | 6.4% | $57.68 | — | COM | 84652J103 |
| — | MIRATI THERAPEUTICS ORD | 597,711 | $61.56M | 6.2% | $53.32 | — | COM | 60468T105 |
| — | DICERNA PHARMACEUTICALS ORD | 3,316,407 | $52.23M | 5.3% | $9.60 | — | COM | 253031108 |
| IRWD | IRONWOOD PHARMA CL A ORD | 4,671,408 | $51.1M | 5.2% | $11.82 | -5.2% | COM | 46333X108 |
| — | MORPHIC HOLDING ORD | 2,266,804 | $44.93M | 4.5% | $19.82 | — | COM | 61775R105 |
| RARE | ULTRAGENYX PHARMACEUTICAL ORD | 497,899 | $31.62M | 3.2% | $57.14 | +11.4% | COM | 90400D108 |
| — | PREVAIL THERAPEUTICS ORD | 2,392,556 | $31.58M | 3.2% | $13.20 | — | COM | 74140Y101 |
| — | ATRECA CL A ORD | 1,486,979 | $28.02M | 2.8% | $18.84 | — | COM | 04965G109 |
| — | CHIASMA ORD | 3,043,827 | $22.74M | 2.3% | $5.00 | — | COM | 16706W102 |
| — | HARPOON THERAPEUTICS ORD | 1,348,423 | $17.53M | 1.8% | $9.47 | — | COM | 41358P106 |
| GOSS | GOSSAMER BIO INC ORD | 772,096 | $17.13M | 1.7% | $20.85 | -8.3% | COM | 38341P102 |
| — | ARQULE ORD | 1,300,000 | $14.31M | 1.4% | $11.01 | — | COM | 04269E107 |
| — | FIBROGEN ORD | 277,500 | $12.54M | 1.3% | $44.16 | — | Call | 31572Q808 |
| — | EIGER BIOPHARMACEUTICAL ORD | 1,136,043 | $12.04M | 1.2% | $11.49 | — | COM | 28249U105 |
| RCUS | ARCUS BIOSCIENCES ORD | 1,488,205 | $11.79M | 1.2% | $14.43 | -30.6% | COM | 03969F109 |
| — | UNITY BIOTECHNOLOGY ORD | 1,044,500 | $9.923M | 1.0% | $14.33 | — | COM | 91381U101 |
| — | CYCLERION THERAPEUTICS ORD | 776,206 | $8.888M | 0.9% | $11.45 | — | COM | 23255M105 |
| PRTA | PROTHENA ORD | 723,300 | $7.645M | 0.8% | $11.89 | -13.6% | COM | G72800108 |
| — | RUBIUS THERAPEUTICS ORD | 463,152 | $7.285M | 0.7% | $23.51 | — | COM | 78116T103 |
| — | ASSEMBLY BIOSCIENCES ORD | 498,300 | $6.723M | 0.7% | $8.38 | — | Call | 045396108 |
| — | SURFACE ONCOLOGY ORD | 2,312,688 | $6.522M | 0.7% | $10.23 | — | COM | 86877M209 |
| — | MERSANA THERAPEUTICS ORD | 1,392,231 | $5.639M | 0.6% | $5.26 | — | COM | 59045L106 |
| — | CURIS ORD | 2,982,208 | $5.547M | 0.6% | $0.69 | — | COM | 231269200 |
| — | AQUINOX PHARMACEUTICALS ORD | 2,265,880 | $5.347M | 0.5% | $2.79 | — | COM | 03842B101 |
| RYTM | RHYTHM PHARMACEUTICALS ORD | 223,167 | $4.91M | 0.5% | $27.64 | -8.6% | COM | 76243J105 |
| — | SOLID BIOSCIENCES ORD | 827,000 | $4.755M | 0.5% | $5.75 | — | COM | 83422E105 |
| — | NGM BIOPHARMACEUTICALS ORD | 316,900 | $4.639M | 0.5% | $14.64 | — | COM | 62921N105 |
| — | KEZAR LIFE SCIENCES ORD | 583,293 | $4.497M | 0.5% | $17.35 | — | COM | 49372L100 |
| — | ADURO BIOTECH ORD | 1,761,421 | $2.713M | 0.3% | $3.98 | — | COM | 00739L101 |
| VCEL | VERICEL ORD | 131,001 | $2.475M | 0.3% | $18.29 | -6.8% | COM | 92346J108 |
| — | SYROS PHARMACEUTICALS ORD | 248,480 | $2.301M | 0.2% | $9.26 | — | COM | 87184Q107 |
| — | REGULUS THERAPEUTICS | 1,111,110 | $1.389M | 0.1% | $1.25 | — | COM | 75915K200 |
| — | GAMIDA CELL ORD | 52,120 | $265K | 0.0% | $5.08 | — | COM | M47364100 |
| — | TCR2 THERAPEUTICS ORD | 16,114 | $231K | 0.0% | $14.34 | — | COM | 87808K106 |